Post-treatment triglyceride-glucose index as survival protective factors in patients with esophageal squamous cell carcinoma

Figure 2 Distribution of triglyceride-glucose index stratified by clinical characteristics and gender. A: Pre-treatment triglyceride-glucose index levels across subgroups defined by age (< 65 years vs ≥ 65 years), Karnofsky Performance Status (70-80 vs 90-100), body mass index (< 24 kg/m²vs ≥ 24 kg/m²), and clinical stage (I-II vs III-IV), comparing female (blue) and male (orange) patients; B: Levels across subgroups defined by age (< 65 years vs ≥ 65 years), Karnofsky Performance Status (70-80 vs 90-100), body mass index (< 24 kg/m²vs ≥ 24 kg/m²), and clinical stage (I-II vs III-IV), comparing female (blue) and male (orange) patients. KPS: Karnofsky Performance Status; BMI: Body mass index; postTyG: Post-treatment triglyceride-glucose; preTyG: Pre-treatment triglyceride-glucose.